未登录

S

Seong Yoon Yi

korea university medicine (ku medicine)

H指数:24

被引数:1,660

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Unveiling the clinical impact of plasma-only mutations in non-small cell lung cancer: a Korean multicenter experience

揭示血浆独有突变在非小细胞肺癌中的临床影响：一项韩国多中心研究

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2025-11-300

PRE

Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18

根据EGFR和ALK状态，不可切除的局部晚期III期NSCLC在确定性同步放化疗后维持Durvalumab的临床结局: 韩国癌症研究小组LU-22-18

JTO CLINICAL AND RESEARCH REPORTS

IF3.5

2024-12-010

OA

Latest results of GVM±R regimen for the salvage therapy of patients with relapsed or refractory aggressive nonHodgkin's lymphoma

GVM±R方案对复发或难治性侵袭性非霍奇金淋巴瘤挽救治疗的最新结果

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Anlotinib combined with chemotherapy in the treatment of first-line extensive-stage small cell lung cancer (ES-SCLC): A real-world study

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

OA

Diagnostic efficacy, performance and safety of side-cut core needle biopsy for thyroid nodules: comparison of automated and semi-automated biopsy needles

IF2.9

2022-01-155

PRE

Axillary Lymphadenopathy on Ultrasound after COVID-19 Vaccination and Its Influencing Factors: A Single-Center Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-01-0318

OAAI

Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma

ANNALS OF HEMATOLOGY

IF2.4

2019-09-0651

PREAI

Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07)

广泛疾病小细胞肺癌患者一线依托泊苷和铂类化疗后帕唑帕尼的维持: 一项多中心，随机，安慰剂对照的II期研究 (KCSG-LU12-07)

BRITISH JOURNAL OF CANCER

IF6.8

2018-01-3036

OAAI

Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02)

RADIOTHERAPY AND ONCOLOGY

IF5.3

2016-02-0140

PREAI

Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience

JOURNAL OF CANCER

IF3.2

2016-01-0124

OAAI

PHASE II TRIAL OF EPIDERMAL GROWTH FACTOR OINTMENT FOR PATIENTS WITH ERLOTINIB-RELATED SKIN EFFECTS

ANNALS OF ONCOLOGY

IF65.4

2014-09-010

PREAI

Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype

IF3.4

2010-10-059

OAAI

Metastatic lymph node in gastric cancer; Is it a real distant metastasis?

IF3.4

2010-01-296

OAAI

Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy

IF3.4

2009-06-2641

OAAI

A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer

IF3.4

2009-04-0939

OAAI

Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy

接受含铂化疗的三阴性乳腺癌患者的治疗结果和临床病理特征

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2008-12-0871

OAAI

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation

BRITISH JOURNAL OF CANCER

IF6.8

2008-07-01134

OAAI

Catecholamine cardiomyopathy associated with paraganglioma rescued by percutaneous cardiopulmonary support - Inverted takotsubo contractile pattern

CIRCULATION JOURNAL

IF3.7

2007-01-0122

OAAI